DuPont de Nemours (NYSE:DD) Price Target Raised to $182.00

DuPont de Nemours (NYSE:DD) had its price objective raised by analysts at UBS Group from $172.00 to $182.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the basic materials company’s stock. UBS Group‘s price target would suggest a potential upside of 20.41% from the stock’s previous close.

Several other research analysts have also recently commented on the company. Citigroup raised their target price on DuPont de Nemours from $162.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday. Zacks Research cut shares of DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 17th. Barclays raised their price objective on shares of DuPont de Nemours from $156.00 to $176.00 and gave the stock an “overweight” rating in a report on Wednesday. Royal Bank Of Canada decreased their target price on shares of DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating on the stock in a research report on Thursday, October 15th. Finally, The Goldman Sachs Group lowered their target price on shares of DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research note on Wednesday, September 30th. Twelve equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $164.75.

DuPont de Nemours Stock Performance

Shares of NYSE DD traded down $2.31 during mid-day trading on Wednesday, hitting $151.15. The company had a trading volume of 2,547,775 shares, compared to its average volume of 1,350,642. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.43 and a quick ratio of 1.82. The business’s 50-day simple moving average is $132.64 and its 200-day simple moving average is $138.51. DuPont de Nemours has a 12 month low of $111.15 and a 12 month high of $157.98. The firm has a market cap of $20.41 billion, a P/E ratio of 335.96, a PEG ratio of 1.31 and a beta of 1.06.

DuPont de Nemours (NYSE:DD) last posted its quarterly earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 EPS for the quarter, beating the consensus estimate of $1.87 by $0.22. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%. The firm had revenue of $1.87 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter in the prior year, the firm posted $1.09 EPS. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. As a group, analysts predict that DuPont de Nemours will post 7.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DuPont de Nemours

Several institutional investors and hedge funds have recently made changes to their positions in the company. Physician Wealth Advisors Inc. raised its position in DuPont de Nemours by 223.1% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company’s stock valued at $27,000 after buying an additional 145 shares during the last quarter. Elevation Wealth Partners LLC lifted its stake in DuPont de Nemours by 168.5% in the 2nd quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company’s stock valued at $32,000 after acquiring an additional 150 shares in the last quarter. DHJJ Financial Advisors Ltd. boosted its position in DuPont de Nemours by 150.0% during the 3rd quarter. DHJJ Financial Advisors Ltd. now owns 250 shares of the basic materials company’s stock worth $32,000 after acquiring an additional 150 shares during the last quarter. Bangor Savings Bank acquired a new position in DuPont de Nemours during the 3rd quarter worth approximately $36,000. Finally, Compass Wealth Management LLC bought a new position in shares of DuPont de Nemours during the 3rd quarter worth approximately $39,000. Institutional investors and hedge funds own 73.96% of the company’s stock.

DuPont de Nemours News Summary

Here are the key news stories impacting DuPont de Nemours this week:

• Positive Sentiment: DuPont beat third-quarter estimates: adjusted EPS was $2.09 versus the $1.87 consensus, while revenue of $1.87 billion topped expectations and rose 4% year over year. Organic sales increased 5%. DuPont Q3 results
• Positive Sentiment: The company raised its full-year 2026 outlook again after exceeding third-quarter guidance, citing strength in healthcare and aerospace demand. It also plans another $250 million in share repurchases in the fourth quarter. Reuters outlook report
• Positive Sentiment: Citigroup raised its target to $176 from $162 and reiterated a Buy rating; Barclays raised its target to $176 from $156 and maintained Overweight. Both targets imply about 16% upside from the quoted share price. Citigroup rating
• Neutral Sentiment: A report highlighted DuPont’s new peptide-purification product, but the available information does not quantify its potential revenue or earnings contribution. Peptide purification product report
• Negative Sentiment: Despite the favorable updates, shares are lower in Wednesday trading following Tuesday’s strong post-earnings advance. The recent articles point to no new negative company-specific development, so profit-taking may be contributing to the pullback.

DuPont de Nemours Company Profile

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.